Luca Benatti serves as the Chief Executive Officer of Tes Pharma S.r.l. since February 2024 and holds board member positions at Quince Therapeutics, CaSRevolution, Metis Precision Medicine, and Newron Pharmaceuticals. Additionally, Luca is a member of the Clinical and Strategic Advisory Boards at Zambon, and has been the Founder and Chairman of IAB - Italian Angels for Biotech since 2017. Previous roles include Chairman of the Scientific Advisory Board at Gain Therapeutics until 2024, and board member at Intercept Pharmaceuticals and EryDel SpA until October 2023.
This person is not in the org chart
This person is not in any teams
This person is not in any offices